losartan has been researched along with fimasartan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, YH; Kim, JH; Kim, TW; Lee, JK; Lee, JY; Lee, KT; Yoo, BW | 1 |
| Kim, JJ; Kim, SK; Kim, YJ; Lee, HY; Lee, SE; Oh, BH; Park, CG; Rhee, MY; Yang, HM | 1 |
| Chin, HJ; Kim, JY; Kim, YJ; Park, S; Ryu, DR; Son, JW; Yoo, TH | 1 |
| Han, BG; Han, SY; Hong, SJ; Hur, KY; Kang, YS; Kim, DK; Kim, S; Kim, YJ; Lee, JP; Lee, S; Na, KR; Park, J; Park, S; Shin, S; Won, JC; Yoo, TH | 1 |
3 trial(s) available for losartan and fimasartan
| Article | Year |
|---|---|
Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-w
Topics: Adolescent; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Severity of Illness Index; Tetrazoles; Treatment Outcome; Young Adult | 2012 |
FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial.
Topics: Adult; Aged; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials, Phase III as Topic; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Endpoint Determination; Humans; Hypertension, Renal; Losartan; Middle Aged; Multicenter Studies as Topic; Nephritis; Prospective Studies; Proteinuria; Pyrimidines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Tetrazoles | 2017 |
The FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC) trial.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus; Diabetic Nephropathies; Double-Blind Method; Humans; Hypertension; Losartan; Proteinuria; Renal Insufficiency, Chronic | 2022 |
1 other study(ies) available for losartan and fimasartan
| Article | Year |
|---|---|
Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Inhibitory Concentration 50; Losartan; Molecular Structure; Protein Binding; Pyrimidinones; Rats | 2012 |